A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Sofosbuvir Impurity 17 - Request Quote

Picture of Sofosbuvir Impurity 17

Sofosbuvir Impurity 17

SZ CAT No:SZ-S010040
CAS No
NA
Mol.F.
C31H26FN3O7
Mol.Wt.
571.6
Inv. Status
Out of Stock

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Sofosbuvir Impurity 17 is chemically (2R,3R,4S,5R)-5-(4-Benzamido-2-oxopyrimidin-1(2H)-yl)-2-((benzoyloxy)methyl)-4-fluoro-4-methyltetrahydrofuran-3-yl benzoate. Sofosbuvir Impurity 17 is supplied with detailed characterization data compliant with regulatory guideline. Sofosbuvir Impurity 17 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Sofosbuvir.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

buy high quality Sofosbuvir Impurity 17

Purchase Sofosbuvir Impurity 17

Sofosbuvir Impurity 17 suppliers

Sofosbuvir Impurity 17 manufacturers

Sofosbuvir Impurity 17 price

Order Sofosbuvir Impurity 17

Enquire Sofosbuvir Impurity 17

Sofosbuvir Impurity 17 cost

Sofosbuvir Impurity 17 Supplier

Sofosbuvir Impurity 17 Distributor

Sofosbuvir Impurity 17 for Method Validation

Sofosbuvir Reference Standard

Sofosbuvir Impurity 17 for ANDA Filing

Sofosbuvir Impurity 17 for Forced Degradation Studies

Sofosbuvir Impurity 17 Identification Standards

Sofosbuvir Impurity 17 for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,